Sign in

CIK 0000014272

  • Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
220790350
Phone
+1 609-252-4621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-10 von Autenried Paul EVP, Chief Information Officer Grant or award · Market Share Units +9,287 9,287
2021-03-10 von Autenried Paul EVP, Chief Information Officer Exercise or conversion · Performance Shares −11,502 0
2021-03-10 von Autenried Paul EVP, Chief Information Officer Grant or award · Performance Shares +13,930 13,930
2021-03-01 Elkins David V EVP, Chief Financial Officer Exercise or conversion +24,579 91,759
2021-03-01 Elkins David V EVP, Chief Financial Officer Shares withheld for taxes −8,573 $61.63 $528K 83,186
2021-03-01 Elkins David V EVP, Chief Financial Officer Exercise or conversion · Restricted Stock Units +24,579 24,577
2021-03-01 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion +23,349 80,572
2021-03-01 VESSEY RUPERT EVP, Research & Early Dev. Shares withheld for taxes −8,944 $61.63 $551K 71,628
2021-03-01 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion · Restricted Stock Units +23,349 23,350
2021-02-04 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion +3,592 58,409
2021-02-04 VESSEY RUPERT EVP, Research & Early Dev. Shares withheld for taxes −1,186 $61.56 $73K 57,223
2021-02-04 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion · Restricted Stock Units −3,592 3,593
2021-02-01 Price Paula A Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 4,535.41
2021-02-01 SATO VICKI L Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 75,689.43
2021-02-01 YALE PHYLLIS R Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 9,009.78
2021-02-01 Vousden Karen H Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 17,779.1
2021-02-01 BERTOLINI ROBERT J Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 26,094.07
2021-02-01 Arduini Peter J Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 31,537.42
2021-02-01 Haller Julia A Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 9,174.75
2021-02-01 Emmens Matthew Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 26,424.7

Page 84 of 90 · 1,795 trades